Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes (original) (raw)
Clinical Care/Education/Nutrition/Psychosocial Research| April 29 2019
1Diabetes Medical Center, Tel Aviv, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other works by this author on:
1Diabetes Medical Center, Tel Aviv, Israel
Search for other works by this author on:
1Diabetes Medical Center, Tel Aviv, Israel
Search for other works by this author on:
1Diabetes Medical Center, Tel Aviv, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Diabetes Unit, E. Wolfson Medical Center, Holon, Israel
Search for other works by this author on:
3Diabetes Unit, E. Wolfson Medical Center, Holon, Israel
Search for other works by this author on:
4Hebrew University, Jerusalem, Israel
Search for other works by this author on:
4Hebrew University, Jerusalem, Israel
Search for other works by this author on:
1Diabetes Medical Center, Tel Aviv, Israel
Search for other works by this author on:
1Diabetes Medical Center, Tel Aviv, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other works by this author on:
1Diabetes Medical Center, Tel Aviv, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other works by this author on:
1Diabetes Medical Center, Tel Aviv, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Diabetes Unit, E. Wolfson Medical Center, Holon, Israel
Search for other works by this author on:
1Diabetes Medical Center, Tel Aviv, Israel
4Hebrew University, Jerusalem, Israel
Search for other works by this author on:
M.Y. and E.R. contributed equally to this work.
Diabetes Care 2019;42(7):1178–1184
Citation
Marianna Yaron, Eytan Roitman, Genya Aharon-Hananel, Zohar Landau, Tali Ganz, Ilan Yanuv, Aliza Rozenberg, Moshe Karp, Maya Ish-Shalom, Joelle Singer, Julio Wainstein, Itamar Raz; Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes. _Diabetes Care 1 July 2019; 42 (7): 1178–1184. https://doi.org/10.2337/dc18-0166
Download citation file:
OBJECTIVE
To assess treatment satisfaction and the effectiveness of a flash glucose monitoring (FGM) system in patients with type 2 diabetes using insulin.
RESEARCH DESIGN AND METHODS
A total of 101 patients with type 2 diabetes on multiple daily insulin injections (MDI) for at least 1 year were assigned randomly to the FGM intervention (n = 53) or the standard care (control) group (n = 48) and followed for 10 weeks. Both groups were instructed to adjust their insulin doses in face-to-face and telephone visits. Satisfaction with treatment, quality of life, comfort using FGM, HbA1c, and frequency of hypoglycemic events were evaluated.
RESULTS
The intervention group found treatment significantly more flexible (P = 0.019) and would recommend it to their counterparts (P = 0.023). Satisfaction using the FGM system was high. The changes in HbA1c were –0.82% (9 mmol/mol) vs. –0.33% (3.6 mmol/mol) in the intervention and control group, respectively (P = 0.005); in nonprespecified post hoc analysis, 68.6% of the patients in the intervention group had their HbA1c reduced by ≥0.5% (5.5 mmol/mol) compared with 30.2% in the control group (P < 0.001), and 39.2% had their HbA1c reduced by ≥1.0% (10.9 mmol/mol) vs. 18.6% in the control group (P = 0.0023) without an increased frequency of hypoglycemia.
CONCLUSIONS
FGM tends to improve treatment satisfaction and may lead to amelioration of glycemic control in patients with type 2 diabetes on MDI without increasing the frequency of hypoglycemia.
© 2019 by the American Diabetes Association.
2019
You do not currently have access to this content.
Sign in
Pay-Per-View Access
$40.00
19,542 Views
171 Web of Science